The Technical Analyst
Select Language :
Denali Therapeutics Inc [DNLI]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Denali Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Denali Therapeutics Inc is listed at the  Exchange

4.48% $20.77

America/New_York / 27 mar 2024 @ 16:00


Denali Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 2 890.35 mill
EPS: -1.060
P/E: -19.59
Earnings Date: May 05, 2024
SharesOutstanding: 139.16 mill
Avg Daily Volume: 1.193 mill
RATING 2024-03-27
C+
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -19.59 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-3.33x
Company: PE -19.59 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 19.46 - 22.08

( +/- 6.29%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-15 Sato Vicki L Sell 1 666 Common Stock
2024-02-15 Sato Vicki L Sell 1 666 Common Stock
2024-02-13 Krognes Steve E. Sell 2 750 Common Stock
2024-02-13 Watts Ryan J. Sell 9 589 Common Stock
2024-02-13 Ho Carole Sell 2 784 Common Stock
INSIDER POWER
47.27
Last 100 transactions
Buy: 1 189 016 | Sell: 501 489

Forecast: 16:00 - $20.77

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $20.77
Forecast 2: 16:00 - $20.77
Forecast 3: 16:00 - $20.77
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $20.77 (4.48% )
Volume 0.768 mill
Avg. Vol. 1.193 mill
% of Avg. Vol 64.36 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Denali Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Denali Therapeutics Inc

RSI

Intraday RSI14 chart for Denali Therapeutics Inc

Last 10 Buy & Sell Signals For DNLI

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$17.24N/AActive
Profile picture for
            Denali Therapeutics Inc

DNLI

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for the treatment of hunter syndrome; DNL343, which is in phase 1 clinical trial the treatment of amyotrophic lateral sclerosis (ALS); AR443820/DNL788 completed a phase I clinical trial for the treatment of ALS, multiple sclerosis (MS), and Alzheimer's disease; and SAR443122/DNL758, which is in phase II clinical trial for the treatment of cutaneous lupus erythematosus. It has collaboration agreement with Takeda Pharmaceutical Company, Genentech, Inc., Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, SIRION Biotech GmbH, Genzyme Corporation, Harvard University, the Michael J. Fox Foundation, and Centogene; and a research and option agreement with Secarna Pharmaceuticals GmbH & Co. KG. to develop antisense therapies in the field of neurodegenerative diseases. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.

Last 10 Buy Signals

Date Signal @
^FTMCMar 28 - 06:2219 808
^FTLCMar 28 - 06:224 382.80
P2PSUSDMar 28 - 06:33204.35
AUCTIONUSDMar 28 - 06:3524.70
FXSUSDMar 28 - 06:30$7.70
ZRXUSDMar 28 - 06:27$1.086
C98USDMar 28 - 06:270.399
WETHUSDMar 28 - 06:243 580.01
MSOLUSDMar 28 - 06:23219.13
ORDIUSDMar 28 - 06:2462.42

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.